A Phase I, Randomized, Single-Dose Study Evaluating the Biosimilarity of TAB008 to Bevacizumab in Healthy Volunteers

Objective: This study compared the pharmacokinetics (PK), safety, and immunogenicity of the biosimilar TAB008 monoclonal antibody to bevacizumab (Avastin(®)) in normal healthy Chinese male volunteers. Methods: In this randomized, double-blind, parallel controlled study, a total of 100 healthy Chines...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jin, Qi, Lu, Liu, Long, Wang, Zejuan, Chen, Gang, Wang, Yu, Liu, Xiaona, Liu, Ying, Liu, Huijuan, Tong, Yuanxu, Liu, Chen, Lei, Chunpu, Wang, Xinghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704343/
https://www.ncbi.nlm.nih.gov/pubmed/31474863
http://dx.doi.org/10.3389/fphar.2019.00905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704343/
https://www.ncbi.nlm.nih.gov/pubmed/31474863
http://dx.doi.org/10.3389/fphar.2019.00905

Ejemplares similares